AMERICAN JOURNAL OF CARDIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2015-03-10 jbourne01

审稿速度:1.0 | 投稿命中率:25.0
经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。

526 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2019-11-01 1463b3a1m11暂无昵称

2019.9.12投稿，现在11.1了还在under review，什么情况？

221 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2020-04-15 147a5fdfm20(暂无昵称)

请问初审大概好久

151 0

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2019-11-17 肥牛宝宝

请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表::
2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表:
2019.9.12投稿，现在11.1了还在under review，什么情况？

188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？

184 0

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2019-09-25 1463b3a1m11暂无昵称

你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?

157 0

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2019-03-07 bigOne

审稿速度:1.0 | 投稿命中率:25.0
经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。

203 0

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2018-11-29 1243bf3dm22(暂无昵称)

你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span

240 0

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2018-11-22 ms9821035889741998

审稿速度:6.0
经验分享：听说很注重文章的创新性

109 0

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2018-11-21 27650313

请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表:
审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果

jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果

250 0

[GetPortalCommentsPageByObjectIdResponse(id=510383, encodeId=f6e9510383a9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿快，投出后2天under review。杂志1月后刷网页，看着当天从review completed 到 proceed with editor到最后的reject。被拒在情理之中，都是自己考虑到的硬伤，但是自己尽力。审稿人2人，分别给出3个和6个意见，非常专业，文章看的也很细致，给之后文章的修改和改投他搞有非常大的指导意义。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=3cb11605664, createdName=jbourne01, createdTime=Tue Mar 10 19:17:00 CST 2015, time=2015-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579172, encodeId=4d565e917216, content=2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588930, encodeId=10055889308b, content=请问初审大概好久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f625233427, createdName=147a5fdfm20(暂无昵称), createdTime=Wed Apr 15 17:15:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580013, encodeId=905f58001383, content=请问现在是什么状态呢？188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？188****2611暂无昵称 2019-11-01 00:00:00 发表: 2019.9.12投稿，现在11.1了还在under review，什么情况？, beContent=188****2611暂无昵称 2019-11-01 发表:: 2019.9.12投稿，现在11.1了还在under review，什么情况？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58dd5203755, createdName=肥牛宝宝, createdTime=Sun Nov 17 00:00:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576920, encodeId=b57e5e692028, content=你们under review 时间变了几次？一般是2个审稿人的话是不是会变2次?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Wed Sep 25 00:00:00 CST 2019, time=2019-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567785, encodeId=52c156e78587, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：期刊很友好。虽然第一次我写的稿子不是特别好，但依然送了外审，给了一些比较中肯的意见，虽然结局是拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 07 20:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563786, encodeId=5a9f563e862e, content=你好基础类的收吗后来有投吗spanclassquote雪墨20181018发表br请问收基础研究类的文章吗偏向于心肌病中基因突变的功能验证span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9cbb2471837, createdName=1243bf3dm22(暂无昵称), createdTime=Thu Nov 29 19:23:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848309, encodeId=3cc28483093b, content=审稿速度:6.0 经验分享：听说很注重文章的创新性 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Thu Nov 22 17:05:33 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563495, encodeId=acf9563495cc, content=请问下你们一般是多久进入under review ?jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, beContent=jiangxiaowei 2017-11-04 10:36:00 发表: 审稿非常快，意见比较好，写了一篇横断面研究，第一个审稿人建议增加分析因素，第二个审稿人直言语言问题及建议增加随访结果, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e3e2327176, createdName=27650313, createdTime=Wed Nov 21 00:00:00 CST 2018, time=2018-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562122, encodeId=d5fb56212280, content=请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJtYwG6N2IAeibrOpQgcOiayH6QWWlVrNQy63I2qBQw5pcEtob14cnAcNJ5SUvY8o4QNfxs88ibS2mxA/132, createdBy=57c72348073, createdName=雪墨, createdTime=Thu Oct 18 14:34:00 CST 2018, time=2018-10-18, status=1, ipAttribution=)]

2018-10-18 雪墨

请问收基础研究类的文章吗？偏向于心肌病中基因突变的功能验证

259 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务